CDC25a Antibody
CDC25a is a member of the CDC25 family of protein phosphatases. CDC25 is involved in promoting the G1 to S phase as well as the G2 to M phase transition of the cell cycle by removing inhibitory phosphates from tyrosine and threonine residues of cyclin-dependent kinases (CDKs). CDC25a is an oncogene and has been found to be overexpressed in a subset of human cancers.
Alternative names for CDC25a Antibody include M-phase inducer phosphatase 1 antibody, dual specificity phosphatase Cdc25a antibody, CDC25A antibody, CDC25A2 antibody.
| Product/Catalog # | Specifications | Price |
|---|---|---|
| CDC25a Antibody A300-075A | Reactivity:
Human Applications: WB, IP |
$314.00 Bulk Quote Data Sheet Add to Cart |
| CDC25a Antibody A300-076A | Reactivity:
Human 100% Sequence Identity:
Applications:
WB, IP, PLA |
$314.00 Bulk Quote Data Sheet Add to Cart |
| CDC25a Antibody S300-075 | Applications:
IP Reactivity: Human Quantity: 0.1 mg antibody/0.4 ml of 50% gel slurry |
$330.00 Bulk Quote Data Sheet Add to Cart |
| CDC25a Antibody S300-076 | Applications:
IP Reactivity: Human Quantity: 0.1 mg antibody/0.4 ml of 50% gel slurry |
$330.00 Bulk Quote Data Sheet Add to Cart |
| CDC25a Antibody AbVantage™ Pack A310-020A | Applications:
WB, IP, PLA Reactivity: Human Quantity: 1 each of A300-075A and A300-076A |
$437.00 Bulk Quote Data Sheet Add to Cart |
Quick Order
Pathways
Featured Collections
- Actin Cytoskeleton
- ATM-ATR Signaling
- COMT and Schizophrenia
- Condensin Complex
- ErbB2 Pathway in Breast Cancer
- GTPase Regulation
- Homologous Recombination
- Inflammation and Cancer
- IRF8 Implications in Disease & Development
- Jumonji and Cancer
- MAPs
- Methylation and Memory Formation
- Mitosis and Cell Cycle Progression
- mTOR
- Mutant EGFR analysis by PLA
- NF-kappa B
- Nucleoporin
- Novel Cancer Biomarkers
- Stat Signaling and Cancer
- SWI/SNF-like
- Translation Initiation
- USP
- WD-repeat
- Wnt Signaling
- XP
Every Bethyl product ships with a 100% guarantee; choose Bethyl antibodies with confidence.
